Dolon Ltd

Dolon is a leading, strategic consultancy specialising in market access for rare disease medicines. We partner and provide strategic guidance to global and national pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society. Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas: Value, Price and...

Pricing and reimbursement,value strategy and communication,market access,orphan disease,strategic pricing,orphan drug and rare disease policy,pricing strategy,market access policy,and rare diseases

Dolon ltd operates in the Business consulting and services industry.

Dolon ltd's revenue is 11m - 100m

Dolon ltd has 51 - 200 employees.